ESR1 and neoplasm: The degradation of ERα could significantly enhance activities by reducing the transcription of genes downstream of ERα and inhibiting the proliferation of ERα-positive breast cancer cells, thus leading to in vivo tumor regression in the MCF-7 mouse xenograft model (Jiang et al., 2018).